Antiplatelet drugs for patients at high cardiovascular risk. Aspirin generally remains the best choice
- PMID: 20027714
Item in Clipboard
Antiplatelet drugs for patients at high cardiovascular risk. Aspirin generally remains the best choice
Prescrire Int.
2009 Dec.
No abstract available
Similar articles
-
Prasugrel: new drug. After angioplasty and stenting: continue to use aspirin + clopidogrel.Prescrire Int. 2009 Oct;18(103):193-5. Prescrire Int. 2009. PMID: 19877380
-
Indications for dual antiplatelet therapy with aspirin and clopidogrel: evidence-based recommendations for use.Ann Pharmacother. 2008 Apr;42(4):550-7. doi: 10.1345/aph.1K433. Epub 2008 Mar 4. Ann Pharmacother. 2008. PMID: 18319394 Review.
-
Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation.Am Heart J. 2004 Mar;147(3):463-7. doi: 10.1016/j.ahj.2003.06.004. Am Heart J. 2004. PMID: 14999195
-
Pro: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regime in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'.Thromb Haemost. 2008 Nov;100(5):752-3. Thromb Haemost. 2008. PMID: 18989515 No abstract available.
-
Ticlopidine and aspirin therapy following implantation of coronary artery stents.Ann Pharmacother. 1997 Jun;31(6):770-2. Ann Pharmacother. 1997. PMID: 9184720 Review.
MeSH terms
Substances
LinkOut - more resources
Medical